Skip to content

Determination of the optimal biomarkers in urine and hair after oral and dermal pesticide exposure in order to quantify the pesticide exposure*

Determination of the optimal biomarkers in urine and hair after oral and dermal pesticide exposure in order to quantify the pesticide exposure* - Determination of biomarkers after pesticide exposure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON43439
Enrollment
36
Registered
2016-06-30
Start date
2016-07-12
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aandoeningen zijn geen onderdeel van deze studie. Doel is namelijk het bepalen van humane biomarkers in urine en haar. Niet van toepassing

Interventions

Each volunteer will be exposed orally and dermally to one of the selected compounds.

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Good general health i.e. no use of prescribed medication (except oral contraceptives); - Age between 18 and 65 years; - BMI between 20 and 25; - Alcohol consumption less than two standard glasses a day; - Caucasian (to minimize genetic differences);

Exclusion criteria

Exclusion criteria: - Pregnancy or willing to become pregnant during the study; - Skin disorders, e.g. atopic eczema, psoriasis, or other chronic skin diseases that causes hyperkeratosis; - Skin abnormalities on the non-dominant forearm, e.g. scars and injuries; - Smoking; - Direct contact or working with pesticides;

Design outcomes

Primary

MeasureTime frame
Concentration of parent compound(s) and/or its metabolite(s) in urine and hair after oral and dermal exposure, including relative metabolite conversion factors and recovery percentages. In addition, the excretion patterns of parents/metabolites in urine over the first 48 hours after administration will be determined.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)